Advanced clinical practice in paediatric haematology and oncology: developing a capability document

Helen Woodman1, Sally Spencer2

  • 1oncology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, England.

Insights

A national framework has been developed to standardize the roles and expertise of advanced clinical practitioners (ACPs) in paediatric oncology and haematology. This aims to ensure consistent, high-quality care for children with cancer.

Area of Science:

  • Paediatric Oncology
  • Advanced Clinical Practice
  • Healthcare Professional Development

Background:

  • Specialist roles like advanced clinical practitioners (ACPs) are crucial for holistic care in paediatric oncology and haematology.
  • A UK survey revealed significant variation in ACP roles and numbers across treatment centres.
  • This highlights a need for a standardized national framework for ACPs in this field.

Purpose of the Study:

  • To describe the development of a capability document for advanced practice in paediatric oncology and haematology.
  • To support and standardize the roles of ACPs in this specialized area.
  • To establish clear delineations of knowledge, skills, and expertise required for ACPs.

Main Methods:

  • Development of a national capability document.
  • Consultation and endorsement by key professional bodies.
  • Reflecting advanced critical thinking, autonomy, and decision-making.

Main Results:

  • A capability document has been created to define advanced practice standards for ACPs in paediatric oncology and haematology.
  • The document has received endorsement from the Children's Cancer and Leukaemia Group and the Royal College of Nursing.
  • It aims to address the variability in roles and expertise observed among ACPs.

Conclusions:

  • The developed capability document provides a standardized framework for advanced practice in paediatric oncology and haematology.
  • It is expected to enhance consistency and quality of care for children with cancer and their families.
  • This initiative supports ACPs in delivering safe and effective advanced care.

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
622
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
722
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
972
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.1K